-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Sunshine Biopharma Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q3 2024.
- Sunshine Biopharma Inc. Depreciation for the quarter ending September 30, 2024 was $64.6K, a 73.7% increase year-over-year.
- Sunshine Biopharma Inc. annual Depreciation for 2023 was $111K, a 436% increase from 2022.
- Sunshine Biopharma Inc. annual Depreciation for 2022 was $20.6K, a 62% increase from 2021.
- Sunshine Biopharma Inc. annual Depreciation for 2021 was $12.7K, a 9.42% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)